TickerFactsScreenerDevelopers

Ovid Therapeutics Inc. (OVID) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2014: $4.85M2015: $69.94M2016: $51.94M2017: $87.13M2018: $36.49M2019: $41.90M2020: $72.03M2021: $187.80M2022: $44.87M2023: $27.04M2024: $26.30M2025: $13.15M$13.15M
2014Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$13.15M-50.0%
2024$26.30M-2.7%
2023$27.04M-39.7%
2022$44.87M-76.1%
2021$187.80M+160.7%
2020$72.03M+71.9%
2019$41.90M+14.8%
2018$36.49M-58.1%
2017$87.13M+67.7%
2016$51.94M-25.7%
2015$69.94M+1343.1%
2014$4.85M—